GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Lasa Supergenerics Ltd

Lasa Supergenerics Q2 FY27: Net Loss of (183.89) Lakhs, Operational Challenges Persist

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 14 Nov 2026, 06:22 PM IST  ·  BSE ID: e00c69f8-eca3-4870-b026-0781bb49a9c8
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a substantial loss and very low sales, as its main factory remains shut after a fire last year.
🤖 AI Summary
  • Lasa Supergenerics reported a net loss of (183.89) Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
  • Revenue from operations stood at 1.24 Lakhs for Q2 FY27, a significant decrease from previous periods.
  • The company continues to face operational disruptions following a fire incident in May 2025 at its primary unit.
  • Uninsured losses of 2,057.47 Lakhs related to the fire incident were recognized in earlier periods.
  • Challenges include an ongoing labour union strike, hindering access for damage assessment, and outstanding GST demand orders of 3,810.93 Lakhs.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
1.24 Lakhs
Not comparable — limited prior period data.
Net Profit / (Loss) after tax (Q2 FY27)
(183.89) Lakhs
Not comparable — limited prior period data.
Basic Earnings per Equity Share (Q2 FY27)
(0.37)
Not comparable — limited prior period data.
Net Profit / (Loss) after tax (Half Year Ended 30.09.2026)
(541.77) Lakhs
Not comparable — limited prior period data.
Uninsured Loss (Exceptional Items)
2,057.47 Lacs
🏢 How This Affects the Company
📈
Business Impact
The cessation of production activities at the primary manufacturing facility, following the fire incident and subsequent disruptions, severely impacts Lasa Supergenerics' ability to generate revenue from operations. This prolonged halt prevents the company from engaging in its core business of Active Pharmaceutical Ingredients (API) manufacturing.
💰
Financial Impact
The company recorded a net loss of (183.89) Lakhs for Q2 FY27 and a half-year net loss of (541.77) Lakhs. Significant uninsured losses of 2,057.47 Lakhs from the fire incident, coupled with contingent liabilities from GST demands aggregating to 3,810.93 Lakhs, place considerable strain on the company's financial position.
⚙️
Operational Impact
All production processes have halted due to the fire incident at the C-4 unit, which was central to primary production activities. An unrecognized labour union strike further obstructs access to the factory, preventing assessment of fire damage and restoration efforts, leading to complete suspension of manufacturing.
⚠️
Risk Impact
The ongoing operational stoppage, uninsured fire losses, and inability to access the factory increase business continuity risk. Contingent liabilities from GST demands and the lack of effective intervention from authorities regarding the labour dispute introduce legal and regulatory risks. The management's inability to restart manufacturing activities poses a going concern risk.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any immediate action based on this filing.
👤
Who Is Affected
All shareholders are affected by the sustained operational challenges and financial losses reported, impacting the company's asset base with Property, Plant and Equipment at 3,662.52 Lakhs as of September 30, 2026.
🔍
Management Signal
Management is actively exploring contract manufacturing or leasing options, indicating an effort to address the inability to commence in-house manufacturing activities and restore business operations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 results — observe any changes in operational status or revenue generation.
Updates on fire damage assessment — monitor progress in gaining factory access for evaluation.
Disclosure on contract manufacturing or leasing arrangements — check for new business models.
HIGH RISK Sustained operational halt, uninsured losses, labor dispute, and significant contingent liabilities pose substantial risks.
💡 Investor Takeaway
Lasa Supergenerics reported a net loss of (183.89) Lakhs for Q2 FY27 with revenue from operations at 1.24 Lakhs. The company's primary manufacturing unit remains non-operational due to a fire incident from May 2025 and an ongoing labour strike, hindering damage assessment and production restart.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Net Loss for Q2 FY27 was (183.89) Lakhs, extending a trend of negative profitability.
  • Revenue from Operations for Q2 FY27 decreased to 1.24 Lakhs from 306.11 Lakhs in Q2 FY26, indicating minimal business activity.
📅 Company Track Record
The company experienced a fire incident at its primary manufacturing unit in Lote Parshuram on May 18, 2025. This event led to the recognition of significant uninsured losses amounting to 2,057.47 Lacs and a complete suspension of production activities at all units.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Lasa Supergenerics' net profit/loss for the quarter ended September 30, 2026?
Lasa Supergenerics reported a net loss of (183.89) Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was Lasa Supergenerics' revenue from operations in Q2 FY27?
Revenue from operations for Lasa Supergenerics in Q2 FY27 (quarter ended September 30, 2026) was 1.24 Lakhs.
What is the status of Lasa Supergenerics' factory operations after the fire incident?
The company's factory operations remain suspended following a fire incident in May 2025, with production activities halted at all units due to damage and subsequent operational challenges including a labour strike.
What exceptional items were recognized by Lasa Supergenerics?
Lasa Supergenerics recognized an uninsured loss of 2,057.47 Lacs as exceptional items in earlier periods due to the fire incident at its factory.
Does Lasa Supergenerics have any outstanding defaults on loans?
No, Lasa Supergenerics reported that the company has no default on loans and debt securities outstanding as on September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel